首页> 外文OA文献 >Isporuka tekućeg pripravka H2-antagonista s lokalnim djelovanjem: Primjena tekućeg ljekovitog oblika koji gelira in situ
【2h】

Isporuka tekućeg pripravka H2-antagonista s lokalnim djelovanjem: Primjena tekućeg ljekovitog oblika koji gelira in situ

机译:递送具有局部作用的H2拮抗剂液体制剂:使用原位凝胶化的液体剂型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

In the present work, a gastroretentive in situ gelling liquid formulation for controlled delivery of ranitidine was formulated using sodium alginate (low, medium and high viscosity grades), calcium carbonate (source of cations) and ranitidine. Prepared formulations were evaluated for viscosity, buoyancy lag time and buoyancy duration, drug content and in vitro drug release. Formulation variables such as concentration of sodium alginate, calcium carbonate and drug significantly affected the formulation viscosity, floating behavior and in vitro drug release. Analysis of the release pattern showed that the drug release from in situ gel a followed diffusion mechanism.
机译:在目前的工作中,使用海藻酸钠(低,中和高粘度等级),碳酸钙(阳离子来源)和雷尼替丁配制了用于控制雷尼替丁递送的胃滞留原位胶凝液体制剂。评价制备的制剂的粘度,浮力滞后时间和浮力持续时间,药物含量和体外药物释放。配方变量(例如藻酸钠,碳酸钙和药物的浓度)显着影响配方粘度,漂浮行为和体外药物释放。释放模式的分析表明,药物从原位凝胶释放遵循扩散机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号